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CHAPTER I
THE PROBLEM
Introduction
Pongileoni's blowing and the scraping of the
anonymous fiddlers had shaken the air in the great
hall, had set the glass of the windows looking on
to it vibrating; and this in turn had shaken the
air in Lord Edward's apartment on the further side.
The shaking air rattled Lord Edward's membrana
tympan i; the interlocked malleus, incus , and stirr-
up bones were set in motion so as to agitate the
membrane of the oval window and raise an infinites-
imal storm in the fluid of the labyrinth. The
hairy endings of the auditory nerve shuddered like
weeds in a rough sea; a vast number of obscure
miracles were performed in the brain and Lord
Edward ecstatically whispered "Bachl -1-
The preceding quotation limns normal auditory commu-
nication. Sound waves enter the ear mixed with ambient
noise present in the communication channel. The ear ana-
lyzes the auditory information and recodes this in the for
of nerve impulses in the fibers of the auditory nerve. The
nerve fibers converge and branch as they ascend along an
elaborate pathway to the brain. Analysis, perception, and
apperception of the impulses probably take place in the sub
cortical and the cortical brain areas. Damage to any part
of this hearing circuit, as a lesion, would have a delete-
rious effect on the processing of the auditory signals.
Fairbanks has studied the speech mechanism and has
m
Aldous Huxley, Point Counter Point (New York:
Harper and Row, 1956), pp. 3^-35.
22interpreted it as a closed cycle system, or servosystem.
The servosy stern employs feedback of the output signal to the
place of control, comparison of the output to the input, and
such manipulation of the output producing device as will
cause the output to have the same functional form as the in-
put. The system involves sensor units which relay data to
the controller unit in the form of feedback signals. The
controller unit includes a storage device which receives and
stores the input and gives off an input signal which is sent
to a comparator and mixer. The comparator functions to form
a calculation between the feedback from the input to derive
an error signal which is fed to the mixer. The error signal
combines with the input to produce the effective driving
signal which is modified so that the future output more
closely approximates the functional form of the input. The
input, then, has been received, compared, and reproduced in
this model.
An important feature of this phenomenon is the stor-
age system which stores al] of the past auditory impressions
of the individual. The auditory impressions are received,
catalogued, associated, retained, and capable of reactiva-
tion by current auditory impressions in this component of
2Grant Fairbanks, "Systematic Research in Experimen-
tal Phonetics: 1. A Theory of the Speech Mechanism as a
Servosystem, " Journal of Speech and Hearing Disorders 19
(1951;), 133-139.
"
3the model
.
Reactivation of past auditory events for compar-
ison with current auditory impressions in the controller
unit
,
and more specifically the storage system, would con-
stitute audi tory discrimination.
The perception and discrimination of auditory stimuli
is b elieved to be located in the temporal lobe. Burr sug-
gest ed that the capacity of memory is located in the temporal
lobe 3also He felt that memory lies in a reverberating neu-
ron circuit
,
or in a feedback system.
In understanding the concept of auditory discrimina-
tion
,
it is necessary to understand the functioning brain
and its rela tionship specifically to auditory discrimination.
Luria viewed the neural organization of the cerebral cortex
as a complex hierarchical system based on the interaction of
separate analysers, the separate parts connected by vertical
and horizont al linkages. Underlying each of the fundamental
sections of the cerebral cortex are the "primary" or "ex-
trinsic" zones, overlaid by "secondary" or "pro jectional-
associative" zones and a third level of organization named
"tertlary" or "intrinsic" zones, entailing several analysers.
Refle cting on contemporary psychology and linguistics,
(Spr
-^Harold S. Burr, The Neural Basis of Human Behavior
ingfield, 111.: Thomas Co., I960).
ed
.
sett
^"Ciba
A. V. S.
s, 19610
Foundation Symposium: Disorders of Language,
De Reuck and Maeve O'Connor (Boston, Massachu-
,
pp. 11^3- 13'0.

of the auditopsychic areas of the controller unit, there is
limited action causing disturbances in the reactivation of
past auditory events in the storage system. Therefore, com-
parison between past and current auditory impressions is less
accurate. The degree of accuracy of judgment in a discrim-
ination task would be diminished.
Prom the discussion of the central auditory nervous
system it is certain that there must be increasing interac-
tion and synchronization of the nerve impulses as they ascend
the auditory pathway. Studies by Bocca and Calearo, Goetz-
ingor, and Jerger support this contention by relating central
auditory dysfunction to poor auditory response on difficult
£67
tasks of auditory discrimination. ' Cases of pathology
of the higher auditory pathways were observed in the greater
than normal breakdown in auditory discrimination between dis-
torted speech and ordinary speech. Central nervous system
destruction or impairment in any zone in the brain stem and
cerebral cortex interferes with the work of the analysers
which participate in the speech and hearing process and leads
E. Bocca and C. Calearo, "Central Hearing Processes,"
Mode rn Developments in Audiology (New York: Academic Press,
1953T7 pp. 337-370.
C. P. Goetzinger, e_fc al., "A Study of Hearing in
Advanced Age," A. M. A. Archives of Otolaryngolo gy. 73
(1961), 662-67I4-.
'James Jerger, "Observations on Auditory Behavior in
Lesions of the Central Auditory Pathways," A. M. A. Archives
of Otolaryngology, 71 (i960), 797-806.
6to disintegration of all functioning systems of speech and
hearing. Any reactivation or stimulation of damaged zones
in the rehabilitation process might provide for more accurate
analysis, better discrimination, or more accurate recall of
past auditory events thus establishing a more competent
speech and hearing system.
Statement of the Problem
In light of current theory regarding central nervous
system processing of auditory information, the present use
of drugs in the study of central nervous system disorders,
and the ever-present need for further research, the present
study will investigate the effects of magnesium pemoline on
speech discrimination on individuals with disorders of the
central nervous system.
The null hypothesis may be stated as such: there will
be no change in speech discrimination ability in subjects
with central nervous system disorders upon the administration
of magnesium pemoline. An alternate hypothesis would be:
there will be a change in speech discrimination ability in
subjects with central nervous system disorders upon the ad-
ministration of magnesium pemoline. More specifically, it
is the purpose of this study to determine if there is a sig-
nificant improvement in speech discrimination tasks in sub-
jects with central nervous system disorders upon the adminis-
tration of magnesium pemoline.
7Importance of the Study
The problem of central nervous system disorders and
their effects is being studied continuously. A number of
factors serve to stimulate further research. Firstly, the
expanding dimensions of warfare lead to brain injuries of
young, productive servicemen. In a society which places a
premium on productivity, rehabilitation for these individuals
and the general welfare of all involved will be a decisive
factor in the role of self-dignity and self-support.
Secondly, the mounting toll of traffic accidents each
year increases the number of severe head injuries resulting
in central nervous system dysfunction. The abrupt and im-
partial selection of the victims of these accidents disrupts
the precious normalcy with rehabilitation offering hope to
regain normal functioning.
Thirdly, modern preventive and curative medicine is
providing an increase in the life expectancy among the older
citizens and a concomitant increase in the number of patients
with central nervous system damage as coronary disease or
hypertension with frequent resultant cerebral impairment
.
There has been an estimate that 1,300,000 mature persons in
the United States have survived cerebral vascular accidents
c
who have varying degrees of impairment. Hudson reports
pMargaret C. Lefevre, "Speech Therapy for the Geriat-
ric Patient," Geriatrics, 12 (1957), 691-695. •
8that by 1975 there will be an estimated 20 million aged per-
o
sons in the United States. Today, there is serious consid-
eration of the socio-economic conditions and opportunities
that confront elderly persons. The recent instigation of
medical and supportive aid through federally sponsored wel-
fare programs available to the aged and others affects the
economy as a whole. Previously these programs were not
available, but now with the available assistance and guid-
ance to provide for needed treatment, rehabilitation is of
paramount importance in offering the individual the opportu-
nity to continue his life, not as a subordinate to society,
but as a member of society. As there is a paucity of infor-
mation available on the rehabilitation of central nervous
system impairments affecting the speech and hearing func-
tioning, there is a definite need to further investigate the
variables that affect the rehabilitation process for these
impairments
.
Recently, research of various pathologies has involved
drug experimentation and investigation. In a relatively un-
investigated area, Cameron reported on the administration of
ribonucleic acid polymerase (RNA) to patients with memory
'Atwood Hudson, "Communication Problems of the Ger-
iatric Patient," Journal of Speech and Hearing Disorder s
,
2£ (I960), 236-21+B
-
:
deficits. Favorable results were noted in many patients;
changes occurred in patients having severe memory deficits
and marked confusion. Orientation returned and there was
considerable restoration of retention. Cameron and Solyom
administered RNA on a double-blind basis to individuals who
suffered cerebrovascular accidents or senile dementia.
After a three week period, the Wechsler Memory Scale and a
counting test were administered to these patients. The re-
sults showed a higher attention span, less confusion, and
more purposeful activity. In many cases, suspension of the
treatment resulted in further decline of memory which was
halted by the re Institution of RNA.
More recently, investigators have been concerned with
a chemical compound consisting of pemoline and magnesium
hydroxide, tradenamed Cylert by Abbott Laboratories of Chi-
12
cago, Illinois. Glasky and Simon have studied the effects
of stimulation by magnesium pemoline upon systems that syn-
13thesize brain nucleic acid with rats in vivo and in vitro. '
D. Ewen Cameron, "The Use of Nucleic Acid in Aged
Patients with Memory Impairment," American Journal of
Psychiatry. Ill; (1958), 9l|-3
.
D. Ewen Cameron and Leslie Solyom, "Effects of
Ribonucleic Acid on Memory," Geriatrics
,
lb (196l), 7k •
Abbott 30).].00: Cylert, a combination of 2-imino-5
phenyl-l|-oxazolidinone and magnesium hydroxine
.
^Alvin J. Glasky and Lionel N. Simon, "Magnesium
Pemoline: Enhancement of Brain RNA Polymerases," Science
,
155 (February 11, 1966), 702-703.
10
The investigators found that there were differential effects
between true RNA and pseudo-polymerase , but the mechanism by
which magnesium pemoline activates the nuclear aggregate
enzymes responsible for RNA synthesis could not be determined
definitely.
Poster, Wing, and Goldstein have engaged in research
in administering the drug magnesium pemoline to study memory
and learning abilities in brain injured patients. With
incomplete results as yet, they recognize the need to con-
tinue investigation into many areas of central nervous system
impairment with magnesium pemoline.
The late D. E. Cameron encouraged further research
by saying,
It (magnesium pemoline) opens the way to an al-
most limitless exploration of new methods of
modifying this extraordinary system whereby we can
bring forward continually the experiences of the
past to modify present actions and future plans. *>
Summary
In this chapter an attempt was made to introduce the
problem of impairment in speech discrimination ability in
central nervous system disorders. The need for further
1
^D. B. Foster, N. Wing, and J. Goldstein, "The Use
of Magnesium Pemoline as an Enhancer of Memory and Learning
Abilities in Brain Damaged Patients," Project No. 379,
Veterans Administration Hospita] , Topeka, Kansas.
15"Neurology" (anon, rev.), Time (June Z\\, 1966), 56.
11
research of this problem was discussed. A statement of the
problem was presented in an effort to structure the direction
of the present investigation for further study of the use
of pharmaceutical agents in central nervous system disorders
.
CHAPTER II
REVIEW OF THE LITERATURE
The direction of the present investigation requires
some acquaintance with relatively complex and esoteric in-
formation concerning the functioning of the central auditory
nervous system and the biological ramifications of the rela-
tionships between nucleic acids, magnesium pemoline, and
central nervous system dysfunction. A review of some of the
literature representative of these areas will be presented.
Central Auditory Function
The auditory nerual pathway is made up of a series of
nerve fibers beginning at the cochlea containing afferent
neurons of the first order. An afferent neuron and hair
cell that excite this neuron constitute a sensory unit. The
sensory units (i.e. hair cells, cilia) somehow initiate nerve
impulses In the fibers of the auditory nerve. The sensory
units are activated in spatial and temporal patterns relating
to frequency, intensity, and timing in cochlear functioning.
Auditory nerve axons conduct these nerve impulses and group
together forming the cochlear nerve, the root of the auditory
nerve. The cochlear nerve runs dorsally and caudally and
laterally to the medial part of the ventral cochlear nucleus.
S. A. Sarkisov, The Struc tures and Functions of the
Brain (Indiana University Press, 1966)
,
pp. 111-116'.
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The axons of the cochlear nerve then divide into ascending
and descending branches, in turn giving off numerous collat-
erals. Axons of the second order, arising in the dorsal and
ventral cochlear nuclei, may run to the region of the supe-
rior olivary complex, mainly on the contralateral side ter-
minating in the superior olive and in the nucleus of the
trapezoid body. Other fibers run into axons of the third
order from nuclei of the superior olivary complex and pass
through the lateral leminiscus to the inferior colliculi.
Generally then, the pathways of auditory conduction consist
of four consecutively joined neurons. The first pass from
the organ of Corti to the primary cochlear nuclei, the sec-
ond run from the cochlear nuclei to the inferior colliculus,
the third extend from the inferior colliculus to the medial
geniculate body, and the fourth pass from the medial genic-
ulate body to the auditory cortex ending in the temporal
region. Additional subcortical structure relaying central
auditory fibers suggests different orders of neurons may run
parallel in the auditory system.
In addition to the anatomical location of auditory
functioning, Burr emphasized the importance of the concept
17
of memory. Into the gray matter of the cortex come a num-
ber of auditory stimuli as intensity, pitch, timbre, loca-
tion, and rhythm. Here the immediate coordinations and
17Burr, p. 101
IV
correlations are carried cut making it possible t o discrimi-
nate the various kinds of sound the ear picks up. He points
out that this discrimination property of the nervous system,
or the cerebral hemispheres as a whole , shows up clearly in
the auditory field. Memory functionin g also has been located
in the temporal lobe. With the concep t of a feedback ar-
rangement, a neuron once activated by a given bit of informa-
tion can move to the output and back t o the input in a con-
tinuously operating circuit. The basis of memory is thought
to be this reverberating circuit. The refore, the temporal
lobe not only receives auditory stimul i coming in to the nerv-
ous system, but also stores this information.
Bocca and Calearo believed that investigat ions of the
central auditory system should be base d upon the evaluation
of disorders of pattern formation and integration , 18 That
is, perception of a sound message does not seem t o be a
choice between single elements, but a choice between inte-
grated units of sound elements. There fore, the central audi-
tory function is an organization of simultaneous or succes-
sive elements into definite patterns. One sound element has
a certain relationship to another sound element. In terms
of this concept of "redundancy" the audi to-psychic area
allows total recognition of a message only partially pre-
sented. This redundancy and perception is a func tion of the
i p
E. Bocca and C. Calearo, pp. 337-370.
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auditory centers in the integration and definition of form.
The integration at the central level involves peripheral
repertoires as well as the dynamic fluctuations in the dura-
tion, intensity, and frequency of stimuli. While the pat-
tern of the verbal message is rigidly structured, so is the
pattern of the activity of the message itself at various
auditory stations and centers. This concept constitutes an
intrinsic redundancy allowing patterns of neural activity to
be discriminated. This redundancy is based on the criterion
of order in the succession and distribution of incoming ver-
bal stimuli afforded by the multiplicity of neural patterns.
From their viewpoint, investigations of the central auditory
system should be based on less structured material, in order
to competently evaluate discrimination ability. By lowering
the redundancy then, the individual with a central auditory
lesion wo\ild have a more demanding discrimination task.
Schuknecht viewed the intelligibility of auditory
19functioning to be located at the central level. ' Auditory
systems in patients with temporal lobe lesions, acoustic
neuroma, or presbycusis infer that lesions involving the
auditory pathway allow reception of a simple pure tone' sig-
nal, but do not handle the complex signals of speech.
Jerger related that, in general, neither cochlear,
^Harold P. Schuknecht, "Perceptive Hearing Loss,"
Laryngoscope 68 (March. 1958). [|.29-l4.39.
16
nor cortical lesions appreciably impair ordinary speech dis-
crimination scores, but that lesions at various sites within
the auditory nervous system may be demonstrated only by the
20
more subtle demands of certain kinds of hearing tests.
Acuity for pure tones seems to be maximally affected by
peripheral lesions, while speech discrimination is reduced
in the bottleneck region of the eighth nerve and in the brain
stem. Therefore, as the site and/or extent of the lesion is
more central to the eighth nerve or brain stem, there is a
concomitant decrease in the successful transmission of com-
plex auditory stimuli.
Cent ral Auditory Dysfunction
Jerger studied unilateral lesions in the central audi-
tory system in observing a left temporal gliobstoma, a left
temporal epilepsy, and a left frontal meningioma in the
21
region of the sphenoid wing. The audiograms evidenced no
abnormalities. Conventional discrimination scores were sat-
isfactory. However, in all cases, discrimination scores for
distorted speech evidenced a performance which was consider-
ably poorer on the ear ipsilateral to the affected temporal
lobe. The alternate loudness matches might infer that the
right ear evoked less intensity than stimuli delivered to
Jerger, pp. 797-8o6.
21 James Jerger, "Auditory Manifestations of Lesions
in the Auditory Nervous System," Laryngoscope 70 (I960). 1+17-
il25.
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the same ear at comparable sensation levels. Jerger sug-
gested that unilateral lesions of the temporal lobe at the
cortical or subcortical level may impair the integrating and
synthesizing function of the central auditory system.
Bocca and others further studied the integrative func-
tion of the cortex on 18 patients who suffered from cerebral
22
tumors affecting one side of the temporal cortex. Results
showed in nearly all cases the failure of normal tone and
speech audiometry to reveal deviations from the normal in
either ear; however, discrimination of distorted voice was
poorer in the ear contralateral to the cortical lesions.
Therefore, it seems that these functional disorders are seen
in the upper stations of the auditory pathways.
Goetzinger and others explored the effects of the dif-
ferences between the sexes and aging on hearing discrimina-
tion and hypothesized additionally that hearing loss and poor
discrimination are of a cortical nature and there would be a
significant relationship between chronological age and the
difficulty of the discrimination test; a simpler discrimina-
tion task would show little or no relation to chronological
23
age. Their findings seemed to support the hypothesis.
Discrimination scores decreased as a function of old age and
22E. Bocca, et al
.
, "Testing 'Cortical' Hearing in
Temporal Lobe Tumours, 7T~Acta Oto Laryngologies l\S (1955),
Fasc. !(., 289- 301+
.
^Goetzinger, pp. 662-6714..
18
this appeared to reflect a cortical dysfunction. However,
the findings indicated that discrimination problems of the
aged are a composite of several factors and could not be
localized to any one level of the auditory system.
Walsh and Goodman also investigated the diagnostic
implications in the relationships between the discrimination
scores and the loss of hearing for speech. By exploring
one case diagnosed as multiple sclerosis, it appeared that
there was a loss for speech of only seven per cent. However,
discrimination scores were 5JI4. per cent and 58 per cent in
the ear contralateral to the central auditory lesion. The
authors stated that it appeared as if central auditory
lesions resulted in poor speech discrimination no matter /
what the hearing loss.
Schuknecht, in reviewing clinical investigations,
tenated that poor discrimination associated with small pure
25tone loss is characteristic of neural degeneration. By
experimentation on cats, 75 pen cent of the ganglion cells
could be lost to certain areas of the cochlea without cre-
ating threshold elevations for frequencies of excitation in
those areas. Further auditory studies on human patients
with acoustic neuroma have shown that while there was only
2
^T. E. Walsh and A. Goodman, "Speech Discrimination
in Central Auditory Lesions," Laryngoscope 65 (1955), 20-25.
2
^Schucknecht, p. 800
.
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a small pure tone threshold loss, there was decreased speech
discrimination. In relating this finding, it could be im-
plied that only a few fibers are needed to carry impulses of
threshold magnitude.
Goetzinger and Rousey believed that speech discrimi-
nation difficulties of the aged could be attributed to a
degenerative reduction in the number of ganglion cells and
fibers of the auditory tract. Degenerative changes of a
cortical nature may also reflect poor speech discrimination.
In either case, there seems to be no hearing loss for pure
tones
.
In recognizing the importance of central nervous sys-
tem functioning in auditory discrimination, the following
review of the literature concerning the effects of certain
independent variables upon central nervous system function-
ing should be of particular interest.
Nucleic Acids and Mental Functioning
Cameron investigated the hypothesis that increased
RNA ingestion can reverse or arrest progression of memory
27
retention failure in the aged. RNA was administered orally
to patients in a pill form in dosages from 2 to 7^ grams
(gm.) daily. In I)|. cases, daily intravenous injections of
C. P. Goetzinger and C. L. Rousey, "Hearing Problems
in Later Life," Medical Time s b7 (1959), 771-780.
27D. E. Cameron, e_t al_., pp. 7^-81.
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increased RNA administration may serve to arrest a progress-
ing memory deficit as improvement of memory was realized
with a mean maximal daily dose of 10.2 gm. which is approxi-
mately twice as much as the daily intake of RNA from natural
sources. While many individual differences were observed,
the authors could not suggest an optimal dosage, but it
seemed that a certain degree of saturation of RNA was neces-
sary to obtain improvement with later reduction to a mainte-
nance dosage. Withdrawal of RNA caused a decline in memory
and treatment was reinstituted for these individuals.
Currently there is revitalized interest in drug
experimentation with the impaired and unimpaired organism.
A particular area of drug investigations has concerned cen-
tral n.ervous system functioning and the drug magnesium pem-
oline. Theoretical speculations about RNA as a substrate
of memory traces and experimentally demonstrated correlations
with the administration of magnesium pemoline has stimulated
lively research with propitious expectations. In that this
is a relatively new and lightly studied area, particularly
in respect to speech and hearing, the representative litera-
ture will be presented in some detail for more complete
understanding.
Drug research with animals
.
One of the first efforts
to demonstrate the effectiveness of magnesium pemoline was
22
28
studied by Glasky and Simon. With a continued interest
in attempting to establish a functional relation between
nucleic acid or protein metabolism and brain function and
to strengthen the hypothesis that nucleic acid functions as
the information engram in the brain, the researchers studied,
in vivo and in vitro, the stimulation by magnesium pemoline
of systems that synthesize brain nucleic acids. Magnesium
pemoline was administered intraperiotoneally to Sprague-
Dawley white rats. The activity was measured both in the
presence of true RNA polymerase and in the presence of
pseudo-RNA polymerase. At various intervals, groups of 6
to 10 animals were sacrificed after treatment with magnesium
pemoline. The brain tissue of both the control and treated
group was collected and the nuclear aggregate preparation
was assayed from both groups for true and pseudo-RNA poly-
merase activities. Results indicated that pseudo-RNA poly-
merase activity was slower than its counterpart, but showed
a continued linear increase in activity as a function of
time. In studying the effect of magnesium pemoline added
in vitro on the activity of an aged enzyme preparation from
brain tissue of nontreated animals by various methods of
isolation, results showed that there was selective enhance-
ment of the enzyme activity and particularly an enhancement
of true RNA polymerase activity. The effect of magnesium
28
A. J. Glasky and L. N. Simon, pp. 702-703
23
pemoline was not observed to be specific and was not neces-
sarily related to the general pharmacological properties of
psychotropic drugs. The data offered no definite informa-
tion concerning the mechanism by which magnesium pemoline
activates the nuclear aggregate enzymes for RNA synthesis.
Possible explanations were: a direct activation of the
enzyme(s), an allosteric alteration of a single enzyme pro-
tein molecule, or an activation of the DNA primer to make
it a more effective template.
Interested in conflicting research results with mag-
nesium pemoline, Simon investigated the effect of magnesium
pemoline on RNA synthesis in rat brain using a completely
on
in vivo test system. Male Sprague-Dawley rats were di-
vided into two groups of six animals each. The animals were
injected with either magnesium pemoline (10 mg./kg., i.p.)
or vehicle (0 .2$$ 2-C-ll}. methoccl) . After 30 minutes,
oratic acid was injected intercranially into each animal.
At the end' of an additional 60 minutes, each animal was
decapitated. The brains were rapidly removed, chilled, and
washed. A 20 per cent homogenate was prepared from each
individual brain. Each sample of each homogenate and puri-
fied nuclei were analyzed for total RNA microgram content.
The results indicated that magnesium pemoline did not cause
29Lionel N. Simon, Magnesium Pemoline: Enhancement
of Brain RNA Synthesis: in vivo . " Permission to cite the
article from the author.

2^
Simon observed that: firstly, while there was an initial
precipitous drop in the (I(.)-NT activity, there was a slow
increase for a period of 2 hours, and there was a threefold
increase in the (l)-NT reaction over the to 2 hour time
period — the conclusion concerning the effectiveness of the
drug does not seem to be justified in recognizing the appar-
ent three-fold increase in (l)-NT activity in preparations
isolated from treated animals; secondly, the untreated prep-
arations may have indicated that the researchers had phys-
ically removed some substance present in the preparation
which inhibited the enzyme and thus the possibility of see-
ing additional activation by pemoline was greatly diminished.
More accurate and comprehensive investigation of the signif-
icance of the results and the importance in the method of
isolation of brain nuclear RNA polymerase were felt to be of
considerable importance in determining the results of the
administration of magnesium pemoline.
In further investigation of the ribosomal system in
the central nervous system mainly involved in protein syn-
thesis, Simon studied the effects of magnesium pemoline on
30
a cell-free ribosomal system isolated from a rat brain.
The results showed that magnesium pemoline had no effect in
vivo or in vitro on the ribosomal system isolated from rat
brain. Simon concludes by experimenting with in vivo
Simon, p. 7.
26
labeling techniques formulating that magnesium pemoline in-
creases the synthesis of brain nuclear RNA supporting the
activation of brain RNA polymerase and that the main mode of
action of magnesium pemoline is to enhance the synthesis of
brain nuclear RNA. In addition, he concludes that magnesium
pemoline has no effect on the major system in the brain re-
sponsible for protein synthesis.
Plotnikoff studied the comparative effects of magne-
sium pemoline and methamphetamine, methylphenidate, and
saline placebo controls on the acquisition and retention of
31
a conditioned avoidance response in rats. Male Sprague-
Dawley rats were used. Magnesium pemoline was given orally
30 minutes prior to the first acquisition trial.
Methamphetamine and methylphenidate were administered to a
second and third group. The testing equipment consisted of
a grid flooring and an escape platform above the grid floor.
The first day rats were given a series of three trials, with
30 second sequencing: 15 seconds inside the chamber without
shock or buzzer, 10 seconds with buzzer, and 5 seconds of
shock with buzzer. These three test trials were used to
select slow learners for subsequent studies. The second day
the rats were given the drug orally 30 minutes prior to the
first acquisition trial of a ten- trial sequence. The third
31
N. Plotnikoff, "Magnesium Pemoline: Enhancement of
Learning and Memory of a Conditioned Avoidance Response,"
Science 'l^l (1966), 703-701+.
27
day retention of the escape response was measured by placing
the test rat inside the chamber for 30 seconds without any
buzzer or shock stimulation. Results of the study showed
that rats treated with magnesium pemoline acquired the proper
response by the second to the third acquisition trial of a
ten-trial sequence, while saline- treated controls only
reached the criterion of learning by the seventh trial. Con-
trols failed to maintain their learned escape response on
the retention trials and there was a rapid decline in per-
formance. Both methamphetamine and methylphenidate were
completely ineffective in altering acquisition or retention
responses in contrast to magnesium pemoline. Methamphetamine
and methylphenidate did not alter retention rates as compared
to the controls. Thus, it was experimentally demonstrated
that magnesium pemoline enhances the acquisition and reten-
tion of a conditioned avoidance response in rats.
Drug re sear ch with humans. One of the initial at-
tempts to examine the effectiveness of magnesium pemoline
32
with humans was investigated by Cameron. He administered
magnesium pemoline to twenty-four men aged !i9 to 85 whose
memories had been impaired by severe hardening of the ar-
teries — senile psychosis. By using a double-blind ap-
proach, one half of the patients received magnesium pemoline
for the first week while the other half received a placebo;
32
"Neurology," p. £6
.
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the conditions were reversed for the second week. The re-
sults recorded on motion picture film, showed that some
patients after taking magnesium pemoline made more accurate
drawings of objects recently shown to them, showed more deci-
siveness in what they remembered, and recalled things faster
than the placebo group. There was significant improvement
for men under 70 for visual presentations and pairings of
words. Dr. Cameron's striking findings and other neurolog-
ical research suggests that memory is not a biochemical sys-
tem and is more than a mere pattern of behavior. A recent
finding that Cameron cited, observed that the nerve cell is
not, as previously held, a fixed and static structure, but
one that continually forms new connections and breaks up old
ones while producing biochemical substances to regulate far-
away organs. Cameron suggested the possibility of a com-
pletely new system of medicine based, not on conventional
drugs and surgery, but on the RNA mediated "memory" inside
every one of the trillions of cells in the body.
Burns and others comparatively investigated the ef-
fects of magnesium pemoline and dextroamphetamine on learn-
33ing in 30 male university student volunteers." Using a
double-blind procedure, each subject was given a single oral
administration of one drug. The five conditions used in the
33John T. Burns, e_fc al., "Effects of Magnesium
Pemoline and Dextroamphetamine on Human Learning " Science
1& (1967), 8^9-851.
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study were: (1) magnesium pemoline, 2^'mg.j (2) magnesium
pemoline, 12.5 mg.; (3) magnesium pemoline, 6.25 mg.; (I4.)
dextroamphetamine, 15 mg.; and (5) placebo. The subjects re-
ceiving 12.5 mg. and 6.25 mg. of magnesium pemoline were
tested after the tests of other drug conditions were com-
pleted. The simpler task was a reaction-time task in which
the correct response to different lights was to press the
button in front of it. The learning task required the sub-
ject to learn which single key was the correct response to
each light when the keys were randomly assigned. Any errors
were related to the subject over an earphone by a brief tone.
The first day of the experiment was a training session. The
first problem was a reaction-time task. Following this, the
subject was instructed to strive for maximum accuracy. The
learning session consisted of 8I4O trials which were balanced
for frequency of stimuli. In observing the learning curve
it could be seen that the period of greatest learning
occurred on Trial 8. Therefore, the period of greatest
learning was the average of proportions of correct responses
in Trials 2 through 9. Results showed that mean learning
rate was fastest under placebo and increasingly slower under
the conditions of magnesium pemoline and dextroamphetamine.
It was further found that the rate of learning for any of the
doses of magnesium pemoline was not significantly different
from the placebo treatment. The higher the dosage of magne-
sium pemoline, the greater was the reduction in the mean rate
30
of learning. While subjects on dextroamphetamine learned
more slowly than subjects on placebo, the dextroamphetamine
group in the simpler reaction-time task had significantly
faster reaction times than the placebo group with no decrease
in accuracy. Dextroamphetamine was the only drug condition
significantly different from the placebo, but even so showed
a slower rate of learning than the placebo group. The behav-
ioral effects of magnesium pemoline in animals have shown
that higher doses inhibit learning. Apparently, the direc-
tion of the differences between placebo and the various doses
of magnesium pemoline is in agreement with this finding. The
results of the study indicated that in the subjects tested,
magnesium pemoline did not enhance learning.
Talland investigated the effects of magnesium pemoline
in the performance of a continuous attention task. The
subjects consisted of 2\\ student volunteers aged between 21
and 2)| years. The subjects were administered a tablet of
2l| mg. of magnesium pemoline or lactose placebo and were
given a rest period for 90 minutes. In subsequent sessions,
the interval between 70 and 90 minutes was used for testing
delayed recall of a narrative text and of a maze learned in
the previous week. The time between 90 and 120 minutes was
used for new learning tests. Then, the subject received his
^George A. Talland, "Improvement of Sustained Atten-
tion with Cylert," Psychonomic Science 6 (1966), 1+9 3 -1-1-91)..
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magnesium pemoline on learning and memory. The subjects
for the experiment were 2l\. student volunteers between the
ages of 21 and 2l|. years. The drug was administered orally
in doses of 25 rag. each at the beginning or 120 minutes
later. A lactose placebo was also given. The two experi-
mental schedules were (l) magnesium pemoline and placebo and
(2) placebo and magnesium pemoline and the control schedule
placebo and placebo. After 90 minutes, the subject being
administered either agent, was given three learning tasks:
a maze test, a narrative text, and a set of figure drawings.
A second agent was administered at the end of the period and
after five minutes of rest, the subject was tested for sus-
tained attention. Following, there was a test of retention
of newly learned material. The results showed that adminis-
tration of magnesium pemoline did not improve or speed up
learning. Also magnesium pemoline did not seem to exert a
systematic influence on those delayed effects of learning
which would allow for inferences to the mental processes of
consolidation or retention. Gains measured in the differ-
ence between information recalled after initial and repeated
learning could be demonstrated only on trials of relearning.
Savings in the number of trials required to reach criterion
performance were greatly increased in the maze learning test
J George A. Talland and Michael T. McGuire, "Tests of
Learning and Memory with Cylert," Psychopharmacologia (Berl.)
10 (1967), kkS-kSl.
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by the administration of magnesium pemoline before relearn-
ing. It was implied by the authors that the drug affected
performance in the repeated learning task rather than re-
tention tasks by strengthening a consolidation process after
original learning. The authors strongly recognize a probable
general stimulant or anti-fatigue effect attributable to mag-
nesium pemoline rather than any influence on learning and
remembering.
Talland and others were interested in the effects of
magnesium pemoline on performance of chronic Korsakov pa-
5/
tients under experimentally controlled conditions. The
performance tasks tested the processes involved in various
aspects of learning and memory. Experiment I investigated
the effect of magnesium pemoline on the acquisition of new
information and on its recall in four patients. Single oral
doses of 50 mg. and placebos were given on a double-blind
procedure. Learning and recall were observed. Results
showed no systematic change in scores among the three treat-
ments, magnesium pemoline, placebo, and no medication, nor
any change attributable to repeated trials. Experiment II
involved three people in the previous experiment excluding
the oldest (fourth) member. Dosage was cut to half (25 mg .
)
for magnesium pemoline and also included methamphetamine
^George A. Talland, et al., "Performance Tests of
Amnesic Patients with CylertT"" The Journal of Nervous and
Mental Disease U+l (1967), 1+21-1+29.
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(10 rag.) and lactose. Experimental procedures again in-
vestigated aspects of learning and memory. One subject
showed improved performance with magnesium pemoline on a
continuous attention task. All subjects improved with mag-
nesium pemoline on the succeeding sessions of a running
memory span test. Experiment III investigated similar
aspects of learning and memory with the same four patients
over a relatively longer period of time. Results were var-
ied, but offered no trend for the effects of magnesium pem-
oline
.
Recently Foster, Wing, and Goldstein initiated a
pilot study to investigate the effects of magnesium pemoline
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on aphasic patients. Objective and subjective evaluations
suggested that the patients on this drug improved noticeably
over placebo controls in mental functioning and noticeably
in speech and language behavior. Interest was stimulated to
manage a more experimentally controlled study of this drug
upon central nervous system disorders.
While no research has directly examined the effect of
magnesium pemoline on speech sound discrimination in central
nervous system disorder's, the preceding, similar studies
have direct references to the questions which this present
study will examine in depth.
^7D. B. Foster, e_t al
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Summary
This chapter has presented a selected review of the
literature relating to the problem under investigation. A
discussion of the function and the dysfunction of the cen-
tral auditory system was presented. The relationship be-
tween nucleic acids and mental functioning was discussed.
Information was presented concerning drug research with ani-
mals and humans. The review of the pertinent literature has
involved the material concerning speech discrimination and,
although indirectly related to speech discrimination, the
state of knowledge concerning the nature of magnesium pem-
oline integral to the appreciation and evaluation of the
present study.
CHAPTER III
PROCEDURES
The research design of the present investigation en-
tails a description of the size of the experiment, the ex-
perimental material, and the experimental treatment. By
following these procedures, it was possible to study the
problem which is the concern of the investigation.
Subjects
The s\ibjects used for the present study were six male
outpatients of the Veterans Administration Hospital at
Topeka, Kansas. The subjects were tested previously for
auditory sensitivity in the hospital admittance testing bat-
tery and were selected because of their central nervous sys-
tem disorder and their inability to evaluate accurately
acoustic or auditory stimuli. The subjects had sufficient
hearing acuity to permit supra-threshold discrimination test-
ing. The verbal responses of the subjects infrequently con-
tained misarticulations . The subjects were adequately in-
tact, both physiologically and psychologically, to partici-
pate in the study.
The subjects could not take any anti-convulsant
,
psychotropic, or central nervous system stimulant drug for
the duration of the study. In compliance with the regula-
tions set forth by the Federal Drug Administration, the
37
physical condition of each subject was monitored carefully
while on the experimental drug. Each subject selected for
this study was informed of its investigational purposes and
signed an agreement (Veterans Administration Form, Number
10-3203, Consent for Use of Picture and Voice), with proper
witnesses, that he understood the use of his performance for
educational and research purposes.
Tests
In observing the difficulty in discriminating auditory
stimuli, simple amplification of speech does not provide an
adequate measure for this impairment. Therefore, the test
events were selected respective to three considerations:
(1) the general hearing sensitivity of the subject, (2) the
speech discrimination ability of the subject, and (3) the
time length of the test session to prevent general physical
fatigue for the patient.
Audiomotric pure tone. This test is a psychophysical
measure to obtain the lowest intensity of a stimulus required
to produce a sensation in a subject or elicit a response from
a subject in relation to normal thresholds of audibility as
specified by the American Standards Association. The partic-
ular procedure used was the Carhart and Jerger modification
of the Hughson-Wostlake technique for obtaining pure tone
thresholds. In this procedure, the subject was given a tone
presentation at 70 decibels hearing level to evoke a response.
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A descent was made from that point in ten decibel steps until
there was no response. Ascents were made in five decibel
steps from the level of inaudibility to the level of the first
response. Threshold was located in ascending trials and was
defined as the minimal level evoking two responses out of
three tone presentations. While the attenuator was being
adjusted for the next level there was a toneless interval.
Tone presentations were for a duration of not less than one
second and not more than two seconds. Test frequencies ad-
ministered wero 500 Hz., 1000 Hz., 2000 Hz., and J4.OOO Hz.
Discrimination. Discrimination tests evaluate the
ability of the listener to understand speech material pre-
sented at an optimum hearing level. A discrimination loss
for speech is the difference between 100 per cent and the
per cent of the given speech material that a listener iden-
tifies or repeats correctly at a level that is sufficiently
high so that a further increase in intensity is not accom-
panied by a further increase in the amount of speech material
repeated correctly.
The first discrimination test used was the C.I.D.
Auditory Test W-22, List 2E . This test consists of 50'
phonetically balanced (PB), monosyllabic words. The list
contains the various speech sounds of English in the rela-
tive frequency of occurrence that approximates the distribu-
tion of speech sounds that would be found in ordinary con-
versation.
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The second discrimination test used was the Rush
Hughes recording of the Harvard P.A.L. Phonetically-Balanced
Word List 7B . The criteria for the selection of words for
this list additionally considers words of equal average dif-
ficulty, equal range of difficulty, representative of English
speech, and in common usage. No particular criteria were
employed in selecting either list, except for the popularity
the lists have enjoyed as clinical tools, especially the
Rush Hughes recording.
Instructions for List 2E and List 7B were as follows:
Directions: You will hear some one-syllable words
on this recording. You will hear them at approxi-
mately the same loudness. Listen carefully and re-
peat as many of the words as you can. If you are
not sure of the word, make a guess. Do not pay at-
tention to any of the phrases before the words, just
repeat the words . Let's try some words for practice:
You will say
. . .
soup
You will say
. . .
park
You will say . . . lake
Here are some others:
Number 1
. .
.
man
Number 2
. .
.
car
Number 3 • • • ran
The third discrimination test used was the Wepman
Auditory Discrimination Test, Form I. The test consists of
a list of forty word pairs. The word pairs may be identical
or they may be minimal pairs — two words that are alike in
all but a single phonetic feature. The test was selected
to study the phenomenon of "phonemic deafness" in speech
discrimination ability. The subject must discriminate
l^o
between sound elements in the word pair.
The following instructions were read before the test:
Directions: On this recording you will hear two
words at a time. I want you to tell me whether the
two words are the same word read twice or two dif-
ferent words read to you. If the two words are
exactly the same say, "Same"; if the two words are
not exactly the same say "Different". Do not pay
attention to the phrases before the words, just
answer whether the words are the same or different.
Let's try some words for practice:
Number 1
. . .
man, man
Number 2
. .
.
hat, pat
Number 3 . . . dog, hog
A previous recording of the two PB lists used in this
study completed by another examiner were borrowed for use in
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this study. List 2E and List 7B were transcribed from new
disc recordings to magnetic recording tape to preserve the
effects of recording conditions and the speakers. The Wepman
test was recorded by a linguist under regulated conditions at
3 3/k iP s onto the master tape. Word pairs were read with a
carrier phrase and approximately a one second pause between
words. The 1000-cycle calibration tone was recorded for each
test in order to adjust the speech gain of the audiometer.
The tests and order of words in the tests were not varied in
sequence of presentation for the duration of the study.
-^Robert S. Brooks and C. P. Goetzinger, "Vocabulary
Variables and Language Skills in the PB Discrimination of
Children," The Journal of Auditory Research 6 (1966), 3^7-
370.
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Instrumentation
The test events for this study were conducted in a
test and control unit, I.A.C. Model 1203. The auditory pure
tones were generated by a Beltone Model 15'C clinical audio-
meter located in the control room. The headphones were
TDH-39 receivers in MX-!|.l/AR ear cushions located in the
test room. The remaining three discrimination tests were
from a master tape recording played on an Eico RP/100 tape
deck. The tape deck was jacked through a Grason Stadler
Speech Audiometer, Model 162. The speech audiometer signal
was amplified by a Citation B, Harmon Kardon solid state
stereo power amplifier which was broadcast over an AR 3, Inc.,
extension speaker located in the test room.
Scotch Brand magnetic recording tape, Number II4.I was
used in the transcription of the W-22, Rush Hughes, and
Wepman recordings. The tape is a heavy duty, silicone lubri-
cated product of the Minnesota Mining and Manufacturing Com-
pany.
Drug Administr
a
tion
Each subject received a prescription of a two week
supply of medication dispensed by the hospital pharmacy.
Magnesium pemoline was of white tablet form in the amount
of 50 mg. per tablet. The placebo was in identical white
tablet form also. The subjects in the study were accustomed
to taking medication and were instructed to take the tablet
h2
every morning for a period of fourteen consecutive days
.
Experimental Design
Each subject acted as his own control for the experi-
menta 1 purposes of this investigation. Following a double-
blind procedure, the subjects and examiner were unaware of
the t ypo of drug being administered for the respective condi-
tions Two conditions were studied: Medication Condition I,
consisting of the administration of either' magnesium pemoline
or piacebo and Medication Condition II, consisting of the ad-
minis tration of the remaining medication, oither magnesium
pemol ine or placebo. The auditory test battery was given
durin g each of these medication conditions and baseline test-
ing was done before and after each treatment constituting
pre- and post-baseline measures. This design thus yielded
five test battery runs as follows:
Trial A. Pre-baseline
Trial 3. Medication Condition I, (magnesium
pemoline or placebo)
Trial C. Post- and Pre-baseline
Trial D. Medication Condition II, (magnesium
pemoline or placebo)
Trial E. Post-baseline
Following this procedure, the resulting data provided
information about the effectiveness or ineffectiveness of the
drug magnesium pemoline upon speech discrimination ability
on individuals with central nervous system disorders.
k3
Research Questions
The following questions wore formulated to explore
the results in detail:
1. Is there a statistically significant difference
between either the Medication Conditions I and II or between
the Medication Conditions I and II and the various baselines,
Trials A, C, and E for List 2E of the C.I.D. Auditory Test
W~22?
2. Is there a statistically significant difference
between either the Medication Conditions I and II or between
the Medication Conditions I and II and the various baselines,
Trials A, C, and E for List 73 of the Rush Hughes version of
the Harvard P.A.L. PB words?
3. Is there a statistically significant difference
between either the Medication Conditions I and II or between
the Medication Conditions I and II and the various baselines,
Trials A, C, and E for the Wepman Auditory Discrimination
Test, Form I?
These particular questions were designed to examine
either (a) the effects of the experimental drug relative to
performances during no particular treatment or (b) the 'effects
of the process of merely administering a "medication" relative
to no treatment. By comparing Medication Conditions I and
II, the real effect of the experimental drug was contrasted
with the possible effects of "medication" by the use of the
placebo
.
Summary
The present chapter has endeavored to describe the
experimental sample, the test materials employed, the instru-
mentation, and experimental design and procedures of the in-
vestigation. In addition, specific research questions were
raised for the purpose of examining in detail the results
of the investigation.
CHAPTER IV
RESULTS AND DISCUSSION
The purpose of this study was to investigate the ef-
fects of the experimental drug, magnesium pemoline, upon
speech discrimination ability on individuals with central
nervous system disorders.
Ana lysis of the Results
The feature investigated in this analysis was auditory
behavior measured by three tests of speech discrimination.
Performances were measured for each subject and test for the
medication conditions which involved the administration of
magnesium pemoline and placebo. Baseline performances were
collected for each subject and test before and after each of
the two medication conditions. The performances of the sub-
jects, in terms of the average percentage of correct re-
sponses, have been presented graphically for the three tests
in the different trials, (see Figure 1). The raw data have
been presented in Appendix B.
The Friedman Two-Way Analysis of Variance was selected
to determine the statistical significance of differences in
the response of the subjects for each test and the different
1+6
92
91
90
89
88
87
86
85
8)|-
83
82
81
80
79
78
77
76
75
C. I. D. W-22
Rush Hughes
WepmanBCD
Performance Trials
E
Figure 1. Average Percentage of Correct Responses for
Three Speech Discrimination Tests: Trial A, Pre-baseline
;
Trial B, Magnesium Pemoline; Trial C, Post- and Pre-baseline;
Trial D, Placebo; Trial E, Post-baseline.
39trials. This particular statistical device is useful for
studying a small sample as used in this study. The scores
for each subject were converted to ranks for each of the five
test trials and cast into a subject by conditions table. If
the scores of the subjects are independent of the conditions,
the distribution of ranks among the conditions would be es-
sentially random. If the scores of the subjects are depend-
ent upon the conditions, then the sum of the ranks for the
respective conditions coxild be expected to vary significantly
The Friedman test determines whether the rank totals under
the various conditions do, in fact, vary significantly. This
type of analysis was done for each auditory test.
C.I.D. W-22 Test. List 2E. The data on speech dis-
crimination ability from this test were obtained for each
subject on the five trials by recording the number of correct
responses to the PB words presented. Examination by inspec-
tion of the scores between trials showed small differences
except in Trial B which involved the administration of mag-
nesium pemoline. Trial B showed the greatest difference in
that, generally, there was an increase in the number of cor-
rect responses. However, the differences among the five
trials were not statistically significant.
39Sidney Siegel, Nonparametric Statis tics for the
Behavioral Sciences (New York: McGraw-Hill Book Company
Inc., 1956), pp. 166-173.
Rush Hughes Test. List 7B . The data on speech dis-
crimination ability from this test were obtained for each
subject on the five trials by recording the number of correct
responses to the P3 words presented. Examination by inspec-
tion of the scores between trials again showed small differ-
ences except in Trial B which involved the administration of
magnesium pemoline. Trial B showed increases in the number
of correct responses, especially for subject number six, (see
Appendix B) . As with the W-22, however, the differences for
the five trials were not statistically significant.
Wepman Auditory Discrimination Test. Form I . The data
on speech discrimination ability from this test were obtained
for each subject on the five trials by recording the number
of correct identifications for the word pairs presented.
Examination by inspection of the scores between trials showed
slight differences in responses, but no pattern was evident
as with the V/-22 and Rush Hughes tests. In comparison with
the inspection of differences for these tests, the differ-
ences in performances did not show changes of the magnitude
previously noted. As might be expected, the five trials did
not yield statistically significant differences.
Analysis of t he Subjects. Similar analyses of var-
iance were performed for examination of subject variation to
determine if there were significant differences between the
subjects. The scores for each subject were converted to
ranks for each of the five trials and cast into a conditions
•1*9
by subjects tabic for each auditory test. If the scores for
the conditions are independent of subject variation, the dis-
tribution of ranks among the subjects would be essentially
random. If the scores of the conditions are dependent upon
systematic variation among the subjects, however, the sum of
the ranks among the subjects would vary significantly.
All three tests of speech discrimination yielded sub-
ject differences significant at the .0001 level. Although
there was no way to attribute these significant differences
to any particular subject except by inspection of the data,
much of the variation observed seemed to be a function of
subject six. This subject scored second lowest on the W-22
test. He obtained the poorest scores on the Rush-Hughes test
under all conditions. The Wepman test did not clearly reveal
variations attributable to a single subject.
Discussion of the Results
The findings for this study revealed that there were
no statistically significant differences in test responses
for the subjects under the various baseline and pharmaceu-
tical conditions. However, observation by inspection of the
data revealed that there were noticeable differences in per-
formance levels for the different tests and subjects under
the various conditions.
By inspection of the data for the C.I.D. W-22 Test,
a general increase was observed in the average number of
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correct responses from Trial A, initial baseline, to Trial
B, Medication Condition I (magnesium pemoline). In further
inspection of the data for the Rush Hughes Test, it may be
observed that a greater number of correct responses were
measured for Trial B, Medication Condition I (magnesium
pemoline), than were measured for any other trial; in fact,
the remaining baseline and placebo trials did not exceed the
initial baseline number of correct responses for this test.
By inspection of the data for the Wepman test, some slight
differences were seen between trials, but these differences
were not of the magnitude as seen in the previous two tests.
In dealing with auditory dysfunction, Schuknecht re-
ported that auditory systems in patients with temporal lobe
lesions, presbycusis or acoustic neuroma which involve the
auditory pathway allow the reception of simple pure tone
signals, but do not handle the complex signals of speech.
Prom these observations auditory functioning is placed at the
central level. Jerger reported that acuity for pure tones
seems to be maximally affected by peripheral lesions, while
speech discrimination is reduced in the bottleneck region of
the eighth nerve and in the brain stem. Therefore, as the
site and/or extent of the lesion is more central to the
eighth nerve or brain stem, there is a concomitant decrease
^°Schuknecht, pp. ^29-I|39
klJerger, pp. 797-606.
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of pattern formation and integration because of the remark-
able "redundancy" of the auditory system. " By lowering the
redundancy of an auditory discrimination task, the individual
would have a more demanding discrimination task. Jerger re-
lated that lesions at various sites within the auditory nerv-
ous system may be demonstrated only by the more subtle de-
mands of certain kinds of hearing tests . !'^ It was seen that
in subject number six, there was the greatest increase in
performance of speech discrimination ability for Trial B,
Medication Condition I (magnesium pemoline) for the Rush
Hughes Test in comparison with the other subjects and tests
used In this study. The Rush Hughes Test has enjoyed pop-
ularity as a clinical tool because of its apparent greater
difficulty due to the verbal presentation and recording char-
acteristics. Subject number six exhibited a lesion of the
eighth cranial nerve and also showed the greatest improvement
in speech discrimination ability on the Rush Hughes Test upon
the administration cf magnesium pemoline. In reference to
the preceding finding, it may be speculated that the effects
of the drug were real, but that the other tests used in this
study did not provide the necessary more subtle and demanding
tasks to elicit a breakdown in speech discrimination ability
^"2Bocca and Calearo, pp. 337-370.
hiJerger, pp. 797-^06
S3
for those subjects with only the highest level lesions.
Goetzinger and Rousey reported in their testing of
elderly subjects that it is not uncommon to find a "differ-
ence score" of approximately 20 per cent between the Hirsh
recordings of the C.I.D. W-22 PB lists and the more difficult
Rush Hughes recordings of the Harvard PB lists.^ When this
normal difference is exceeded the authors suggested there may
be dysfunctions of the higher auditory pathway. It is curious
to notice that the subjects in the present study seem to be
almost equal in the performances on the ¥-22 and Rush Hughes
tests; even subject number six, although exhibiting the
greatest change for the Rush Hughes test upon drug adminis-
tration, did not yield a 20 per cent difference score between
the two trials. For the subjects tested in this study, the
identical two tests did not elicit a breakdown in speech dis-
crimination ability. Therefore, it is suggested that future
attempts to investigate the effect of magnesium pemoline upon
speech discrimination ability in central nervous system dis-
orders consider the implementation of more demanding tasks
of speech discrimination.
Summary
The results of the study revealed by inspection that
there were differences in responses for the subjects upon
^"Goetzinger and Rousey, pp. 771-780.
the administration of magnesium pemoline. Upon statistical
analysis, however, the responses for the subjects on the
baseline and medication conditions were not significant In-
different . It was concluded that the experimental drug
either (a) had no effect upon speech discrimination ability
in individuals with central nervous system disorders as in-
vestigated in this study, or (b) that the tests employed were
not siafficient for demonstrating any effects present. It
was further speculated on the basis of the performance of
one subject that there may be a differential effect on the
eirhth cranial nerve upon the administration of magnesium
pemoline suggesting that this agent is selective in acting
upon first order neurons, but not on higher pathways. Sug-
gestions were made for implementing more demanding tests and
for the selection of a more specific test sample.
CHAPTER V
SUMMARY AND CONCLUSIONS
In light of the current theory regarding central
nervous system processing of auditory information, the cur-
rent use of drugs to study central nervous system disorders,
and the need for further research in this area, the present
study investigated the effects of magnesium pemoline upon
speech discrimination ability on individuals with central
nervous system disorders. This study investigated the null
hypothesis that there would be no change in speech discrim-
ination ability in subjects with central nervous system dis-
orders upon the administration of magnesium pemoline.
A selected review of the literature presented a dis-
cussion of the function and dysfunction of the central nerv-
ous system. Information was presented concerning nucleic
acids and the experimental drug, magnesium pemoline.
In this study six subjects were used who were out-
patients at the Veterans Administration Hospital In Topeka,
Kansas. The subjects were selected because of their central
nervous system disorder and their inability to evaluate
accurately acoustic or auditory stimuli. Each subject re-
ceived a two week supply of medication of either magnesium
pemoline or placebo as the condition required. Each subject
acted as his own control. The subjects and examiner were
unaware of the type of drug being administered for the

Si
upon the administration of this drug may provide promising
areas for research in the future. Further attempts to in-
vestigate the effectiveness of this drug should consider the
particular sample of subjects to provide for the eventual
exposition of this potentially valuable recourse for reha-
bilitation purposes.
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APPENDIX A
1. that
2. ill
3. knee
k. pew
5. star
6. and
7. tree
8. odd
9. dumb
10. ham
11. smart
12. wi th
13. off
11*. thin
13'. gave
16. now
17. send
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C.I.D. Auditory Test W-22, List 2E
18. move 35. live (verb)
19. ice 36. hit
20. eat 37. by (buy)
21. rooms 38. chest
22. cars 39. show
23. air (heir) 1+0
.
cap
2)|. new (knew) Ip. ail (ale)
25\ jaw l{2. tare (tear)
26. well 1|3. hurt
27. die (dye) 111} way (weigh)
28. one (won) l\$ else
29. then I4.6. does
30. own !+7. yore (your)
31. bin (been) 1|.8
.
too (two, to)
32. key 1|9. flat
33. oak 50. ease
3)4.. young
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Rush Hughes PB £0, List 73
1. fling 18. shaft 35. chop
2. pig 19. knit 36. woo
3. aim 20. comes 37. dwarf
k. though 21. but 38. sniff
5. coast 22. sag 39. plod
6. gun 23. pounce U0
.
by
7. act 21].. him 1+1 meet
8. grade 25. scout 1|2 pent
9. roar 26. rich k3 . am
10. dope 27. g«sp l|i| . sin
11. rash 28. fake l)-5 • whip
12. wire 29. nine 1+6. off
13. shave 30. mud 1|7 range
ll|. raid 31
.
south I4.8 cut
15. fort 32. sledge 1)9. dose
16. quiz 33. siege £0. jug
17. woe 3l|-. cook
Wepman Auditory Discrimination Test
Form I
6k
1. tub - tug 21. cat - cap
2. lack - lack 22. din - bin
3. web - wed 23. lath - lash
k. leg - led 2k. bum - bomb
5. chap - chap 25. clothe - clove
6. gum - dumb 26. moon - noon
7. bale - gale 27. shack - sack
8. sought - fought 28. sheath - sheaf
9. vow - thou 29. king - king
10. shake - shape 30. badge - badge
11. zest - zest 31. pork - cork
12. wretch - wretch 32. fie - thigh
13. thread - shred 33. shoal - shawl
Ik. jam - jam 3k • tall - tall
15. bass - bath 35. par - par
16. tin - pin 36. pat - pet
17. pat - pack 37. muff - muss
18. dim - d in 38. pose - pose
19. coast - to a s t 39. lease - leash
20. thimble - symbol ho. pen - pin
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Subject 1
Subject 1 was a 68 year old, white male. During his
working life, he served in the positions of a coach and an
athletic director. He was married. He had a fifteen year
history of high blood pressure and arteriosclerosis. He
suffered a heart attack in 194-9 and a coronary thrombosis in
1951. The individual suffered a cerebral thrombosis in 1965'
resulting in speech impairment and right hemiplegia which is
presently in almost complete remission. The subject suffered
a cerebral vascular accident in 1966. He also exhibited an
acute involutional psychotic reaction to his condition mani-
fested by moderate to severe depression.
Diagnosis: (1) Chronic brain syndrome
(2) Hypertensive arteriosclerotic
heart disease
(3) Osteoarthritis
(4) Residual right hemiplegia
Prognosis: Good
Subject 2
Subject 2 was a £8 year old, white male. He completed
a high school education. His occupations included a psychi-
atric aide and welder. Pie was married and a parent. In
December, 196£ the subject suffered a sudden onset of severe
weakness of the left arm and leg.
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Diagnosis: (1) Cerebral vascular accident, probably
secondary to thrombosis of right
middle cerebral artery with left
hemiparesis severe
(2) Depressive reaction mild, associated
with diagnosis (1)
Prognosis: Fair for improvement in the left paresis
Subject 3
Subject 3 was a 60 year old, Negro male. The subject
did not complete high school, but has completed several cor-
respondence courses. He was a former maintenance worker.
He was married. The subject suffered a cerebral vascular
accident in September, 1966 resulting in right hemiparesis
predominant in the distal right arm.
Diagnosis: (1) Cerebral thrombosis due to
arteriosclerosis vessel indeter-
minate with right hemiparesis and
focal motor seizures
(2) Chronic brain syndrome associated
with arteriosclerosis
Prognosis: Favorable
Subject L|.
Subject I| was a 1|6 year old, white male. He completed
a high school education. He was formerly employed as a sales-
man. He was married. The subject had a documented history
of neurological problems including leg weakness and Bell's
Palsy intermittent since 1914-2. In 1963, there was a general
muscle weakness. Examination showed signs of brain stem
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involvement along with some loss of cortical functioning and
emotional lability . There was mild impairment of higher in-
tegrative functioning. The neurological examination showed
spotty sensory and motor deficits in both hemispheres, mostly
on the left
.
Diagnosis: (1) Multiple sclerosis, manifested by a
spastic ataxic gait
Prognosis: Fair adjustment
Subject $
Subject £ was a I4.6 year old, white male. The subject
had a high school education. He was twice-divorced. The
subject had experienced l£ years of progressive muscle wast-
ing and gradual restriction of life. Neurological examination
indicated some mild impairment of auditory discrimination.
He exhibited a combination of mild intellectual impairment
and generalized muscular atrophy.
Diagnosis: (1) Myotonia atrophica, chronic,
unimproved
Prognosis: Poor
Subject 6
Subject 6 was a 56 year old, white male. The subject
was a college graduate. He formerly was employed as an
accountant. He was married and a parent. The subject ex-
perienced a gradual progression of hearing loss and anomalies
since 191+7 . In September, 1965, a right sub-occipital
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craniotomy was completed with total removal of an acoustic
neuroma. The subject also had emphysema and diabetes
mellitus controlled by diet. The subject exhibited memory
impairment and higher cognitive impairment reflected by the
extremely concreistic nature of his thought processes. Exam-
ination showed VII, VIII, IX, and X cranial nerve damage on
the right side
.
Diagnosis: (1) Right acoustic neuroma, improved
post-operatively
Prognosis: Not available
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The purpose of the present study was to investigate
the effects of magnesium pemoline upon speech discrimination
ability of individuals with central nervous system disorders.
Language is behavior viewed as a complex system of codes
organized into a system of phonemes, each of which singles
out definite and persistent sound cues from the flow of
speech. By phonemic evaluation, there may be discrimination
of the definite units of speech. With a disturbance In the
sensory analyses of sounds, there is difficulty in discrim-
inating the acoustic cues. Central nervous system destruction
or impairment in any zone in the brain stem and cerebral cor-
tex interferes with the work of the analysers which partici-
pate in the speech and hearing process leading to disintegra-
tion of all functioning systems of speech and hearing.
Studies of the hearing system have placed the intelli-
gibility of auditory functioning at the central level. Tem-
poral lobe lesions, acoustic neuroma, or presbycusis infer
that lesions involving the auditory pathway allow the recep-
tion of simple pure tone signals, but do not handle the
complex signals of speech.
Investigators have been studying the effects of the
chemical compound magnesium pemoline. There have been the-
oretical speculations about ribonucleic acids as a substrate
of memory traces and experimentally demonstrated correlations
with the administration of magnesium pemoline. It has been
2reported that upon the administration of magnesium pemoline
to animals that there is an increase in the acquisition and
retention of learned behavior. Other research with humans
presented conflicting reports about the effect of magnesium
pemoline upon learning. Some investigators reported that
magnesium pemoline may act as a general stimulant or have an
anti-fatigue effect property, rather than have any direct
effect on learning and memory.
The present study used six subjects who were out-
patients at the Veterans Administration Hospital at Topeka,
Kansas. Each subject exhibited a central nervous system dis-
order and an inability to evaluate accurately acoustic or
auditory stimuli. Each subject received a two week supply
of medication, either magnesium pemoline or placebo as the
test condition required. The study was directed on a double-
blind basis. Each subject acted as his own control. An
auditory test battery comprised of three tests of speech dis-
crimination was administered during the medication conditions.
Baselines were administered before and after each medication
condition.
The results of the study indicated that there was no
increase in speech discrimination ability upon the adminis-
tration of magnesium pemoline to individuals with central
nervous system disorders. Upon the application of the
Friedman Two-Way Analysis of Variance to the data, the per-
formances of the subjects did not yield statistically
3significant differences for any of the tests used in the
study.
In observing the results from other investigators, it
was concluded that either the experimental drug had no ef-
fect upon the subjects used in the present study or that the
tests employed in the study were not sufficient for demon-
strating any effect present. Prom the data of one subject
with a lesion of the eighth cranial nerve, a speculation was
made that this drug may be selective in acting upon first
order neurons, but not on higher pathways. Further attempts
to study this drug should consider the implementation of more
.demanding tests and the selection of a more specific test
sample
.
